Impact of chemotherapy and/or immunotherapy on neutralizing antibody response to SARS‐CoV‐2 mRNA‐1237 vaccine in patients with solid tumors

Impact of chemotherapy and/or immunotherapy on neutralizing antibody response to SARS‐CoV‐2 mRNA‐1237 vaccine in patients with solid tumors

Patients with solid tumors have been a risk group since the beginning of the SARS‐CoV‐2 pandemic due to more significant complications, hospitalizations or deaths. The immunosuppressive state of cancer treatments or the tumor itself could influence the development of post‐vaccination antibodies. Thi...

Full description

Bibliographic Details
Main Authors: Eudald Felip, Edwards Pradenas, Margarita Romeo, Silvia Marfil, Benjamin Trinité, Víctor Urrea, Ainhoa Hernández, Ester Ballana, Marc Cucurull, Lourdes Mateu, Marta Massanella, Bonaventura Clotet, Teresa Morán, Julià Blanco
Format: Article
Language:English
Published: Wiley 2023-04-01
Series:Molecular Oncology
Subjects:
adverse reactions
anticancer therapy
cancer
COVID‐19
moderna vaccine
neutralizing antibodies
Online Access:https://doi.org/10.1002/1878-0261.13359

Internet

https://doi.org/10.1002/1878-0261.13359

Similar Items